Mr. Chair and honourable member, thank you for the question.
As you'll remember, earlier in this year we had many meetings where we were under intense pressure to get the number of vaccines out there, and we had strategies to require vaccines for our portfolio-style approach. Now that we are getting further along in our immunization program, as you point out, there are opportunities to make choices. There's nothing for us to say on that topic at this time, but that's an active topic of discussion. Thank you for the question, sir.